Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women

Gynecological Endocrinology

Volumn 24, Issue 3, 2008, Pages 154-157

  Fanta, Michael ^a,c   Cibula, David ^a   Vrbíková, Jana ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^c NONE   (Czech Republic)

Author keywords

17 hydroxyprogesterone; 21 hydroxylase deficiency; Hyperandrogenemia; Oligomenorrhea; PCOS

Indexed keywords

HYDROXYPROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACNE; ADRENAL HYPERPLASIA; ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; NONCLASSIC ADRENAL HYPERPLASIA; OLIGOMENORRHEA; OVARY DISEASE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; STEROID 21 MONOOXYGENASE DEFICIENCY; TESTOSTERONE BLOOD LEVEL;

17-ALPHA-HYDROXYPROGESTERONE; ACNE VULGARIS; ADRENAL HYPERPLASIA, CONGENITAL; ADRENOCORTICOTROPIC HORMONE; BODY MASS INDEX; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 40549131552     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590801911992     Document Type: Article

References (19)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011.
3. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-2438.
4. Azziz R, Nestler JE, Dewailly D. Androgen Excess Disorders in Women. Lippincott-Raven 1997;177.
5. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985;37:650-667.
6. Azziz R, Dewailly D, Owerbach D. Non-classic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 1994;78:810-815.
7. Morel Y, David M, Forest MG, Bétuel H, Hauptman G, Andre J, Bertrand J, Miller WL. Gene conversions and rearrangements cause discordance between inheritance of forms of 21-hydroxylase deficiency and HLA types. J Clin Endocrinol Metab 1989;68:592-598.
8. Moran C, Azziz R. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Semin Reprod Med 2003;21(3):295-300.
9. Romaguera J, Moran C, Diaz-Montes TP, Hines GA, Cruz RI, Azziz R. Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. Fertil Steril 2000;74(1):59-62.
10. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC. A prospective study of the prevalence of clearcut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 1994;41:231-236.
11. Arnaout MA. Late-onset congenital adrenal hyperplasia in women with hirsutism. Eur J Clin Invest 1992;22(10):651-658.
12. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients. J Clin Endocrinol Metab 2004;89(2):453-462.
13. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 2006;91:2-6.
14. Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, Pugeat M, Rohmer V, Speiser PW, Witchel SF. 21-Hydroxylase- deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study. Am J Obstet Gynecol 2000;183:1468-1474.
15. Spritzer P, Billaud L, Thalabard JCh, Birman P, Mowszowicz I, Raux-Demay MC, Kuttenn F, Mauvais-Jarvis P. Cyproterone Acetate versus Hydrocortisone Treatment in Late-Onset Adrenal Hyperplasia. J Clin Endocrinol Metab 1990;70:642-666.
16. Carmina E, Lobo RA. Ovarian supression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Fertil Steril 1994;62(4):738-743.
17. Ciampelli M, Fulghesu AM, Cucinelli F, Pavone V, Ronsisvalle E, Guido M, Caruso A, Lanzone A. Impact of of insulin and bodmass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism 1999;48:167-172.
18. Cibula D, Hill M, Fanta M, Sindelka G, Zivny J. Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome? Hum Reprod 2001;16:940-944.
19. Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR. Screening for 21-hydroxylase deficient non-classic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999;72:915-925.